Drugs / Monovalent A/H1N1 influenza vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00971100 | Aug 2009 → Mar 2010 | swine influenza | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Monovalent A/H1N1 influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00971100 ↗ |
| Modality | Vaccine | “new swine-origin influenza A/H1N1 virus monovalent subunit vaccine” NCT00971100 ↗ |
| Route | Intramuscular | “2 IM injections” NCT00971100 ↗ |